<DOC>
	<DOCNO>NCT02589548</DOCNO>
	<brief_summary>The study prospective registry Hodgkin Lymphoma ( HL ) patient Brazil . The purpose study gather clinical , epidemiologic outcome data treatment HL , basis record collect key Brazilian institution , centralize web-based registry clinical data verify central board hematopathologists .</brief_summary>
	<brief_title>Brazilian Prospective Hodgkin Lymphoma Registry</brief_title>
	<detailed_description>Hodgkin Lymphoma consider one malignancy high cure rate . Its prognosis improve substantially along last three decade , result relevant cooperative study carry American European institution . Around 70-80 % patient cure available chemotherapy regimen . However , data HL develop country scarce . It well establish patient underprivileged society present malignancy advance stage . In study HL patient treat Brazil 80 's , patient present advanced disease . The creation registry patient HL provide reliable picture disease country , prevalence different area socioeconomic group , treatment outcome . It also foster establishment network among hospital region country , may serve platform development cooperative study engage main Brazilian Institutions . The data collection allow comparison data enter registry predefined rule range consistency data field registry . Also , quality assurance address data validation data analysis . Standard descriptive analysis carry . For crude association analysis , categorical data analyse use chi-square Fisher 's exact test ( two-sided ) . Survival curve estimate use Kaplan-Meier method compare use log-rank test . Univariate multivariate Cox regression analysis conduct verify prognostic factor regard Progression free survival Overall survival , adjust relevant prognostic clinical variable treatment .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Previously untreated HL patient Clinical data include baseline information disease localization laboratory parameter stag , feature treatment adopt assurance followup update least 5 year request Written inform consent</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Hodgkin Lymphoma</keyword>
	<keyword>Hodgkin Disease</keyword>
</DOC>